Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 691.85 -28.55  | -3.96% -7.40% 34.86 19,494.31
NSE Price: Feb 12, 15:55 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Feb 12, 15:55 691.85 -28.55 -3.96% 726.00 720.40 1,706,690 671.10 - 726.00
BSE Feb 12, 15:53 690.90 -29.15 -4.05% 725.00 720.05 182,010 671.50 - 726.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 1,111,986 P/B: 6.19 NSE Code: GLENMARK
52-Week Range: R 712.00 - 1,262.90 Dividend Yield: 0.29% BSE Code: 532296
TTM EPS: R 19.82 Book Value: R 111.58 Face Value: R 1
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -21.86 -14.49 -24.17 -3.81 13.70 20.31 16.00
S&P BSE Sensex -12.12 -7.55 -11.27 -19.56 5.65 5.30 8.54
S&P BSE Healthcare -9.93 -5.16 -7.71 -0.60 24.38 20.15 15.00
Company's return has been calculated on basis of NSE's price.
As on Feb 11, 2016
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.28 17.70 21.46
Net Profit -12.90 0.78 7.50
EPS -12.37 0.98 7.82
Book Value 0.55 7.60 4.85
Average
Operating Margin 15.93 18.37 19.66
Net Margin 7.22 9.67 11.06
Return on Networth 15.88 19.73 20.19
Return on Investment 12.02 14.91 14.90
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - 3.24 -1.10
Operating Profit - 38.88 32.00
Net Profit - 48.09 1,505.53
EPS - 42.36 1,439.62
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 19,494.31 7,326.47 1,631.10 21.99 15.88 6.19 34.86
Lupin 78,888.42 13,105.46 2,027.96 15.24 31.09 7.58 39.24
Sun Pharmaceutical Inds. 204,169.51 7,459.76 -1,213.08 -16.05 24.89 7.26 52.37
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 1,500 765.30 11.48
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Sep 01, 2014 Blanche Elizabeth Saldanha  Buy Market 27,758 720.45 199.98
Fund Houses invested in the stock
Fund Dec-15 Sep-15 Jun-15 Mar-15 Dec-14
DSP BlackRock Mutual Fund 0.645 0.815 0.399 0.129 0.148
Birla Sun Life Mutual Fund 0.317 0.644 0.863 0.677 0.273
Sundaram Mutual Fund 0.256 0.214 0.193 - -
SBI Mutual Fund 0.195 0.008 0.121 0.057 -
HDFC Mutual Fund 0.114 0.074 0.074 0.115 0.102
Kotak Mahindra Mutual Fund 0.101 0.115 0.085 0.065 0.144
HSBC Mutual Fund 0.085 0.093 0.187 0.166 0.120
Baroda Pioneer Mutual Fund 0.067 0.019 - - -
Principal Mutual Fund 0.066 0.055 0.073 0.038 0.038
JM Financial Mutual Fund 0.066 0.005 0.071 0.010 0.073
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: webmaster@glenmarkpharma.com

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: einward.ris@karvy.com

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.25
Piotroski F-Score
3
Modified C-Score
4
5-Years Price to Earnings
34.29
5-Years Price to Book
6.09
Earnings Yield
EBIT / Enterprise value
1.39%
PEG
Price / Earnings to growth ratio
2.68
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R661.95 +3.57%
Cadila Healthcare R306.35 -4.21%
Cipla R528.60 -2.26%
Divi's Laboratories R987.15 -3.18%
Dr. Reddy's Lab R2,847.45 -1.31%
Glaxosmithkline Pharma R3,222.25 +0.63%
Lupin R1,756.30 -1.95%
Piramal Enterprises R953.60 +1.98%
Sun Pharmaceutical Inds. R847.35 +2.04%
Torrent Pharmaceuticals R1,235.05 -2.45%
As on Feb 12, 15:59